Skip to main content

LIVE

BLCO

Bausch + Lomb Corporation

BLCO

NYSE·Healthcare·Medical - Instruments & Supplies·Mkt cap $6.4B

$18.04

-0.55%

P/E

-37.66

Mkt Cap

$6.4B

52-Wk Range

$13.77–$18.92

52-Week Range

$13.77 - $18.92

P/E

-37.66

Fwd P/E

22.87

Beta

0.56

Div Yield

0.00%

Avg Vol

444.8K

Shares Out

356.5M

Mkt Cap

$6.4B

Price action

Price chart

Up 16.2% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • 170+ year heritage and brand recognition in eye health
  • Diversified product portfolio across three complementary segments
  • Extensive global distribution network and market penetration
  • Proprietary pharmaceutical formulations and surgical technology

Bear Case

2 risks

  • Low volatility (beta 0.6).
  • Premium valuation to Medical Devices peers

Growth

Turning profitable

Aging global population increasing demand for eye care treatments

Value

Premium valuation to Medical Devices peers

Momentum

Strong

+18.8% over 3m

Quality

Strong

Excellent business quality

Dividend

None

No dividend

Earnings track record

Latest print - beat on both lines

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Nov 4, 2026

Q3 26 RECAP

JUL 29, 2026

Reported EPS of $0.16 vs $0.15 consensus (+3.6% surprise). Revenue of $1.4B vs $1.4B expected (+1.8%). Beat on both top and bottom lines.

EPS beat +3.6%
Rev beat +1.8%
Double beat

EPS surprise · last 4Q

1 of 1 beats

Estimate

Actual

Q3 26

+3.6%

Revenue trend · last 8Q

+5%

+7%

+10%

+9%

+9%

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

Q2 26

$1.2B

$1.3B

$1.1B

$1.3B

$1.3B

$1.4B

$1.2B

$1.4B

Margins · last 8Q

Gross

56.5%

Operating

6.0%

Profit

-1.0%

Wall Street consensus

4 analysts · 75% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

3

75%

Hold

1

25%

Sell

0%

Median Price Target

Latest: HC Wainwright · Aug 28, 2026

vs Industry

How BLCO stacks vs Medical - Instruments & Supplies

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.